Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran
Abstract Background In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan provi...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Population Health Metrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12963-021-00260-5 |
id |
doaj-52876a66c312424a9d4ad452275dadbc |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fatemeh Sadeghi Bahman Cheraghian Zahra Mohammadi Sadaf G. Sepanlou Sahar Masoudi Zahra Rahimi Leila Danehchin Yousef Paridar Farhad Abolnezhadian Mohammad Noori Seyed Ali Mard Ali Akbar Shayesteh Hossein Poustchi |
spellingShingle |
Fatemeh Sadeghi Bahman Cheraghian Zahra Mohammadi Sadaf G. Sepanlou Sahar Masoudi Zahra Rahimi Leila Danehchin Yousef Paridar Farhad Abolnezhadian Mohammad Noori Seyed Ali Mard Ali Akbar Shayesteh Hossein Poustchi Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran Population Health Metrics Hypertension Iran 2017 ACC/AHA hypertension guideline JNC8 hypertension guideline Risk factors Prevalence |
author_facet |
Fatemeh Sadeghi Bahman Cheraghian Zahra Mohammadi Sadaf G. Sepanlou Sahar Masoudi Zahra Rahimi Leila Danehchin Yousef Paridar Farhad Abolnezhadian Mohammad Noori Seyed Ali Mard Ali Akbar Shayesteh Hossein Poustchi |
author_sort |
Fatemeh Sadeghi |
title |
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran |
title_short |
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran |
title_full |
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran |
title_fullStr |
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran |
title_full_unstemmed |
Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran |
title_sort |
impact of 2017 acc/aha guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of iran |
publisher |
BMC |
series |
Population Health Metrics |
issn |
1478-7954 |
publishDate |
2021-05-01 |
description |
Abstract Background In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan province, southwest of Iran, and to estimate the number of people who are eligible for non-pharmacologic and pharmacologic intervention. Methods This population-based cross-sectional study was conducted in Khuzestan, a large province in the southwest of Iran. Comprehensive information about the potential relating factors of hypertension was collected, blood pressure was measured, and anthropometric measurements were obtained. Moreover, the dietary pattern was evaluated in 2830 individuals, using a qualitative food frequency questionnaire. Results Among 30,506 participants, 30,424 individuals aged 20–65 years were eligible for the study. In comparison with the previous guideline released by the Joint National Committee (JNC8), the prevalence of hypertension in Khuzestan dramatically increased from 15.81 to 42.85% after implementation of the ACC/AHA guideline, which was more dominant in the male population and the 45–54 age group. The sex and age adjustment of the hypertension prevalence was estimated to be 39.40%. The percentage of hypertension awareness, treatment, and control were 45.85%, 35.42%, and 59.63%, which dropped to 22.72%, 26.37%, and 28.94% after implementation of new guideline, respectively. Conclusions In the ACC/AHA guideline, a higher number of individuals with the pre-hypertension condition were shifted into the hypertension category and the level of awareness, treatment, and control were dramatically decreased, which highlight a great need to expand the public health infrastructure for further managing the substantial increased burden on healthcare system. However, further studies with population over 65 years are required to estimate the eligibility for antihypertensive treatment in this province after implementation of new guideline. |
topic |
Hypertension Iran 2017 ACC/AHA hypertension guideline JNC8 hypertension guideline Risk factors Prevalence |
url |
https://doi.org/10.1186/s12963-021-00260-5 |
work_keys_str_mv |
AT fatemehsadeghi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT bahmancheraghian impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT zahramohammadi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT sadafgsepanlou impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT saharmasoudi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT zahrarahimi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT leiladanehchin impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT yousefparidar impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT farhadabolnezhadian impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT mohammadnoori impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT seyedalimard impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT aliakbarshayesteh impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran AT hosseinpoustchi impactof2017accahaguidelineonprevalenceawarenesstreatmentcontrolanddeterminantsofhypertensionapopulationbasedcrosssectionalstudyinsouthwestofiran |
_version_ |
1721420712031289344 |
spelling |
doaj-52876a66c312424a9d4ad452275dadbc2021-05-30T11:07:55ZengBMCPopulation Health Metrics1478-79542021-05-0119111110.1186/s12963-021-00260-5Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of IranFatemeh Sadeghi0Bahman Cheraghian1Zahra Mohammadi2Sadaf G. Sepanlou3Sahar Masoudi4Zahra Rahimi5Leila Danehchin6Yousef Paridar7Farhad Abolnezhadian8Mohammad Noori9Seyed Ali Mard10Ali Akbar Shayesteh11Hossein Poustchi12Department of Global Public Health, Karolinska InstituteAlimentary Tract Research Center, Imam Khomeini Hospital Clinical Research Development Unit, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical SciencesLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical SciencesDigestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical SciencesLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical SciencesHearing Research Center, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical SciencesBehbahan Faculty of Medical SciencesSchool of medicine, Dezful University of Medical SciencesShoshtar Faculty of Medical SciencesAbadan Faculty of Medical SciencesAlimentary Tract Research Center, Imam khomeini Hospital Clinical Research Development Unit, School of Medicine, Ahvaz Jundishapur University of Medical SciencesAlimentary Tract Research Center, Imam khomeini Hospital Clinical Research Development Unit, School of Medicine, Ahvaz Jundishapur University of Medical SciencesLiver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical SciencesAbstract Background In 2017, the American College of Cardiology/American Heart Association (ACC/AHA) provided a new guideline for hypertension prevention and management. We aimed to update the prevalence, awareness, control, and determinants of hypertension based on this guideline in Khuzestan province, southwest of Iran, and to estimate the number of people who are eligible for non-pharmacologic and pharmacologic intervention. Methods This population-based cross-sectional study was conducted in Khuzestan, a large province in the southwest of Iran. Comprehensive information about the potential relating factors of hypertension was collected, blood pressure was measured, and anthropometric measurements were obtained. Moreover, the dietary pattern was evaluated in 2830 individuals, using a qualitative food frequency questionnaire. Results Among 30,506 participants, 30,424 individuals aged 20–65 years were eligible for the study. In comparison with the previous guideline released by the Joint National Committee (JNC8), the prevalence of hypertension in Khuzestan dramatically increased from 15.81 to 42.85% after implementation of the ACC/AHA guideline, which was more dominant in the male population and the 45–54 age group. The sex and age adjustment of the hypertension prevalence was estimated to be 39.40%. The percentage of hypertension awareness, treatment, and control were 45.85%, 35.42%, and 59.63%, which dropped to 22.72%, 26.37%, and 28.94% after implementation of new guideline, respectively. Conclusions In the ACC/AHA guideline, a higher number of individuals with the pre-hypertension condition were shifted into the hypertension category and the level of awareness, treatment, and control were dramatically decreased, which highlight a great need to expand the public health infrastructure for further managing the substantial increased burden on healthcare system. However, further studies with population over 65 years are required to estimate the eligibility for antihypertensive treatment in this province after implementation of new guideline.https://doi.org/10.1186/s12963-021-00260-5HypertensionIran2017 ACC/AHA hypertension guidelineJNC8 hypertension guidelineRisk factorsPrevalence |